Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boaz Hirshberg

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Current Diabetes Reports|August 10, 2007
Lessons learned from the international trial of the edmonton protocol for islet transplantationBoaz Hirshberg
Current Diabetes Reports|July 31, 2009
Implications of the 2008 update from the collaborative islet transplant registryBoaz Hirshberg
Current Diabetes Reports|July 20, 2010
The cardinal features of recurrent autoimmunity in simultaneous pancreas-kidney transplant recipientsBoaz Hirshberg
Current Diabetes Reports|August 2, 2006
Can we justify living donor islet transplantation?Boaz Hirshberg
Current Diabetes Reports|July 18, 2008
Benefits of simultaneous islet-kidney transplantation versus simultaneous pancreas-kidney transplantationBoaz Hirshberg
Current Diabetes Reports|July 22, 2005
Can statins reduce the incidence of new-onset diabetes post transplantation?Boaz Hirshberg
Current Diabetes Reports|September 16, 2015
Insights from cardiovascular outcome trials with novel antidiabetes agents: what have we learned? An industry perspectiveBoaz Hirshberg, Arie Katz
Diabetes Care|April 29, 2011
Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugsBoaz Hirshberg, Itamar Raz
Diabetes Care|July 25, 2013
Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerationsBoaz Hirshberg, Arie Katz
Diabetes/Metabolism Research and Reviews|June 6, 2003
Islet transplantation: where do we stand now?Boaz Hirshberg, Kristina I Rother, David M Harlan
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Current Diabetes Reports|August 10, 2007
Lessons learned from the international trial of the edmonton protocol for islet transplantationBoaz Hirshberg
Current Diabetes Reports|July 31, 2009
Implications of the 2008 update from the collaborative islet transplant registryBoaz Hirshberg
Current Diabetes Reports|July 20, 2010
The cardinal features of recurrent autoimmunity in simultaneous pancreas-kidney transplant recipientsBoaz Hirshberg
Current Diabetes Reports|August 2, 2006
Can we justify living donor islet transplantation?Boaz Hirshberg
Current Diabetes Reports|July 18, 2008
Benefits of simultaneous islet-kidney transplantation versus simultaneous pancreas-kidney transplantationBoaz Hirshberg
Current Diabetes Reports|July 22, 2005
Can statins reduce the incidence of new-onset diabetes post transplantation?Boaz Hirshberg
Current Diabetes Reports|September 16, 2015
Insights from cardiovascular outcome trials with novel antidiabetes agents: what have we learned? An industry perspectiveBoaz Hirshberg, Arie Katz
Diabetes Care|April 29, 2011
Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugsBoaz Hirshberg, Itamar Raz
Diabetes Care|July 25, 2013
Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerationsBoaz Hirshberg, Arie Katz
Diabetes/Metabolism Research and Reviews|June 6, 2003
Islet transplantation: where do we stand now?Boaz Hirshberg, Kristina I Rother, David M Harlan
Pageof 10